Last updated: March 21, 2023
Sponsor: Massachusetts General Hospital
Overall Status: Terminated
Phase
N/A
Condition
Stasis Dermatitis
Vascular Diseases
Deep Vein Thrombosis
Treatment
N/AClinical Study ID
NCT03904602
2018 JIE
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- history of CVI (Clinical classification 1-5), with > 2+ edema of the lower legs,
- > 2+ peripheral pulses (popliteal, dorsalis pedis [DP], and posterior tibial [PT]) oraudible biphasic / triphasic Doppler signal, if pulses not palpable.
Exclusion
Exclusion Criteria:
- open venous stasis ulcer(s) or other wounds on lower legs
- lymphedema or risk factors for lymphedema
- acute heart failure with active management
- known deep vein thrombosis (DVT) with subtherapeutic anticoagulation
- peripheral arterial disease (PAD) with reduced / absent pulses
- known or suspected inferior vena caval (IVC) compression
- circumference of lower leg < 45 cm or > 115 cm (size limits of small and extra-largeEdemaWear®)
- severely altered mental status or lacking capacity to consent.
Study Design
Total Participants: 3
Study Start date:
August 19, 2019
Estimated Completion Date:
September 15, 2019
Study Description
Connect with a study center
Massachusetts General Hospital
Boston, Massachusetts 02114
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.